Try GOLD - Free
India cuts China bulk-drug reliance
Mint New Delhi
|March 17, 2025
Bulk drugs accounted for 63% of the total pharmaceutical imports in the country during FY 2018-19
Indian companies have started manufacturing important bulk drugs or active pharmaceutical ingredients (APIs) under the government's production linked incentive (PLI) scheme.
The production of Penicillin G and Clavulanic Acid began in October last year. Other APIs already in production include Atorvastatin, Sulfadiazine, Telmisartan, Olmesartan, Para Amino Phenol (raw material for paracetamol) and Oxcarbazepine.
The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.
These bulk drugs are largely used as antibiotics and to manage non-communicable diseases such as cardiovascular diseases, chronic respiratory diseases, and diabetes.
This story is from the March 17, 2025 edition of Mint New Delhi.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint New Delhi
Mint New Delhi
In a sea of tech talent, companies can’t find the workers they want
There has rarely, if ever, been so much tech talent available in the job market.
4 mins
October 03, 2025
Mint New Delhi
H-1B clampdown may extend to US college faculty
Rising anti-immigration sentiment in the US is no longer confined to moves to limit foreign technology workers from entering the country. Lawmakers are now turning their attention to universities, professors and researchers as well.
2 mins
October 03, 2025
Mint New Delhi
Govt scans e-commerce cos’ COD charges, refund delays
The government will examine if cash-on-delivery charges imposed by online retailers are aimed at nudging consumers to pay upfront, and why refunds are delayed or blocked if prepaid orders are cancelled, said two people aware of the matter.
2 mins
October 03, 2025
Mint New Delhi
Why India's best students face a tough job market
Students entering this year's placement season are stepping into a rough job market.
2 mins
October 03, 2025
Mint New Delhi
GST boom ahead?
India's latest goods and services tax (GST) revenue figures paint an optimistic picture.
1 min
October 03, 2025
Mint New Delhi
FPIs pull record ₹2 tn on valuations, weak rupee
Heavy outflows could cap market gains; Nifty returns just 0.3% in dollar terms
2 mins
October 03, 2025
Mint New Delhi
Hexaware sued for $500 million in US over patent breach
American IT services firm Natsoft Corp. has sued Hexaware Technologies Ltd for breach of contract and patent infringement, seeking $500 million in damages from the latter, in one of the biggest patent cases against an Indian IT firm.
3 mins
October 03, 2025
Mint New Delhi
WHY INDIA IS SEEKING A NEW SUNRISE IN JAPAN
India missed out on Japanese investment in its initial post-reform years. That could change now
7 mins
October 03, 2025
Mint New Delhi
Art, play and a side of burgers
A Mint guide to what's happening in and around your city
1 min
October 03, 2025
Mint New Delhi
Silicon screen: Movie guns bet on AI content
With increasing focus on and need for production of AI-generated content to scale pipelines and speak to younger audiences, many film industry veterans are exploring partnerships with companies specialising in AI or launching their own ventures.
1 mins
October 03, 2025
Listen
Translate
Change font size